Quick Answer
Xenon Pharmaceuticals Inc. reported Net Income of -$345.91 million for fiscal year 2025.
Xenon Pharmaceuticals Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$345.91M | -47.6% |
| 2024 | -$234.33M | -28.5% |
| 2023 | -$182.39M | -45.5% |
| 2022 | -$125.37M | -58.9% |
| 2021 | -$78.88M | -173.5% |
| 2020 | -$28.84M | +30.7% |
| 2019 | -$41.59M | -20.6% |
| 2018 | -$34.50M | -12.4% |
| 2017 | -$30.70M | -33.5% |
| 2016 | -$23.00M | -46.0% |
| 2015 | -$15.75M | -221.0% |
| 2014 | $13.02M | +8.2% |
| 2013 | $12.03M | +379.7% |
| 2012 | -$4.30M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$90.90M | -44.8% | -7.3% |
| June 30, 2025 | -$84.71M | -46.2% | -30.2% |
| March 31, 2025 | -$65.05M | -35.7% | -3.6% |
| September 30, 2024 | -$62.79M | -29.6% | -8.4% |
| June 30, 2024 | -$57.92M | -22.0% | -20.8% |
| March 31, 2024 | -$47.93M | -14.9% | +1.1% |
| September 30, 2023 | -$48.46M | -30.4% | -2.1% |
| June 30, 2023 | -$47.46M | -52.3% | -13.7% |
- Xenon Pharmaceuticals Inc. showed a decrease of -47.6% in Net Income compared to the prior fiscal year.
- Over the 2012–2025 period, Xenon Pharmaceuticals Inc.’s net income has declined by 7942.5% (from -$4.30 million to -$345.91 million).
- The most recent figure is from Xenon Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: